Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Engelhardt

Showing results (181-190 of 255) with videos related to

Pageof 26
Sort By:
BMC Medical Informatics and Decision Making|December 16, 2018
Inventory of oncologists' unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancerEllen G Engelhardt, Dóra Révész, Hans J Tamminga, et al.
BMJ Open|November 2, 2023
(Cost-)effectiveness of an individualised risk prediction tool (PERSARC) on patient's knowledge and decisional conflict among soft-tissue sarcomas patients: protocol for a parallel cluster randomised trial (the VALUE-PERSARC study)Anouk A Kruiswijk, Michiel A J van de Sande, Rick L Haas, et al.
Vaccine|December 10, 2017
Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016Justin R Ortiz, Julian Hickling, Rebecca Jones, et al.
Frontiers in Immunology|April 16, 2019
Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of ImmunizationYoshita Bhide, Wei Dong, Inta Gribonika, et al.
Journal of Cancer Survivorship : Research and Practice|November 27, 2019
Cancer-related cognitive problems at work: experiences of survivors and professionalsKete M Klaver, Saskia F A Duijts, Ellen G Engelhardt, et al.
Msphere|July 28, 2021
Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative StudyJoanna Waldock, Lingyi Zheng, Edmond J Remarque, et al.
Frontiers in Immunology|October 26, 2018
Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza VaccinesWei Dong, Yoshita Bhide, Federica Sicca, et al.
Bone Marrow Transplantation|June 26, 2010
Regulatory T cell expression of CLA or α(4)β(7) and skin or gut acute GVHD outcomesB G Engelhardt, M Jagasia, B N Savani, et al.
Ejhaem|March 12, 2021
New-onset post-transplant diabetes mellitus after haploidentical hematopoietic cell transplant with post-transplant cyclophosphamideBrendan L Mangan, Dilan Patel, Heidi Chen, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 30, 2019
Early viral reactivation despite excellent immune reconstitution following haploidentical Bone marrow transplant with post-transplant cytoxan for sickle cell diseaseDilan A Patel, Nathalie Dhedin, Heidi Chen, et al.
Pageof 26

Showing results (181-190 of 255) with videos related to

Sort By:
Pageof 26
BMC Medical Informatics and Decision Making|December 16, 2018
Inventory of oncologists' unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancerEllen G Engelhardt, Dóra Révész, Hans J Tamminga, et al.
BMJ Open|November 2, 2023
(Cost-)effectiveness of an individualised risk prediction tool (PERSARC) on patient's knowledge and decisional conflict among soft-tissue sarcomas patients: protocol for a parallel cluster randomised trial (the VALUE-PERSARC study)Anouk A Kruiswijk, Michiel A J van de Sande, Rick L Haas, et al.
Vaccine|December 10, 2017
Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016Justin R Ortiz, Julian Hickling, Rebecca Jones, et al.
Frontiers in Immunology|April 16, 2019
Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of ImmunizationYoshita Bhide, Wei Dong, Inta Gribonika, et al.
Journal of Cancer Survivorship : Research and Practice|November 27, 2019
Cancer-related cognitive problems at work: experiences of survivors and professionalsKete M Klaver, Saskia F A Duijts, Ellen G Engelhardt, et al.
Msphere|July 28, 2021
Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative StudyJoanna Waldock, Lingyi Zheng, Edmond J Remarque, et al.
Frontiers in Immunology|October 26, 2018
Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza VaccinesWei Dong, Yoshita Bhide, Federica Sicca, et al.
Bone Marrow Transplantation|June 26, 2010
Regulatory T cell expression of CLA or α(4)β(7) and skin or gut acute GVHD outcomesB G Engelhardt, M Jagasia, B N Savani, et al.
Ejhaem|March 12, 2021
New-onset post-transplant diabetes mellitus after haploidentical hematopoietic cell transplant with post-transplant cyclophosphamideBrendan L Mangan, Dilan Patel, Heidi Chen, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 30, 2019
Early viral reactivation despite excellent immune reconstitution following haploidentical Bone marrow transplant with post-transplant cytoxan for sickle cell diseaseDilan A Patel, Nathalie Dhedin, Heidi Chen, et al.
Pageof 26